| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP2346512A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 07/27/2011 | EP1841780B1 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/27/2011 | CN102134269A Nitrooxy derivatives of glucocorticoids |
| 07/27/2011 | CN102133410A Immunotherapy of B cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
| 07/27/2011 | CN102133196A Potassium ion binding polymers for pharmaceutical compositions |
| 07/27/2011 | CN101496828B Use of total saponin extract of fenugreek |
| 07/26/2011 | US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 07/26/2011 | CA2673461C 5.alpha.-androstane-3,6,17-trione (kneller's trione) and methods of use therefor |
| 07/26/2011 | CA2603185C Propane-1,3-dione derivative or salt thereof |
| 07/26/2011 | CA2422974C Medicaments based on progestins for dermal use |
| 07/26/2011 | CA2334315C Compounds with growth hormone releasing properties |
| 07/26/2011 | CA2267743C Low dose estrogen interrupted hormone replacement therapy |
| 07/21/2011 | WO2011088188A1 Use of an adrenal hormone-modifying agent |
| 07/21/2011 | WO2011087187A1 Composition for protecting fetal nerve cells comprising vitamin c |
| 07/21/2011 | WO2011085643A1 Fused pyridine derivatives |
| 07/21/2011 | US20110178133 Calcium receptor modulating agents |
| 07/21/2011 | US20110178006 Method for administering glp-1 molecules |
| 07/21/2011 | US20110177138 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules |
| 07/21/2011 | US20110177097 Methods for modulating expression of creb |
| 07/21/2011 | US20110177056 Non-cytotoxic fusion proteins comprising egf muteins |
| 07/21/2011 | US20110177039 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells |
| 07/21/2011 | DE102010004986A1 New bromocriptine is prolactin inhibitor, useful for initiating, without concurrent medication, prolactin increase in male and female depressed patients for normalization of mood, and for treatment of reactive and endogenous depression |
| 07/21/2011 | CA2786443A1 Use of an adrenal hormone-modifying agent |
| 07/20/2011 | EP2344494A1 Aminotriazolopyridines and their use as kinase inhibitors |
| 07/20/2011 | EP2344475A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 07/20/2011 | EP1361884B1 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 07/20/2011 | CN1951965B Glp-1衍生物 Glp-1 derivatives |
| 07/20/2011 | CN102131825A N-glycosylated human growth hormone with prolonged circulatory half-life |
| 07/20/2011 | CN102131821A Glucocorticoids attached to nitrate esters via aromatic linker in position 21 and their use in ophthalmology |
| 07/20/2011 | CN102131803A Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 07/20/2011 | CN102131498A Composition comprising somatotrophic hormone |
| 07/20/2011 | CN102127072A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127070A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127037A Tanshinone compounds and applications thereof |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/20/2011 | CN102125560A Uses of DPP-IV inhibitors |
| 07/20/2011 | CN101700233B Method for preparing gonadorelin freeze-dried powder injection |
| 07/20/2011 | CN101690778B Chinese medicinal preparation for treating insulin resistance symptoms and preparation method thereof |
| 07/20/2011 | CN101648933B 3,4-dihydro-4-oxygen-2H-1-chromene mannich base compound as well as preparation method and application thereof |
| 07/20/2011 | CN101300000B Equol level regulator |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2509390C Method of treatment of prostate cancer and composition for treatment thereof |
| 07/19/2011 | CA2487722C New etonogestrel esters |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/14/2011 | WO2011084453A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases |
| 07/14/2011 | WO2010106383A8 Novel crystalline form of antiprogestin cdb-4124 |
| 07/14/2011 | US20110172267 TSH receptor antagonizing tetrahydroquinoline compounds |
| 07/14/2011 | US20110172249 Method for improving absorbability of preparation, and preparation having improved absorbability |
| 07/14/2011 | US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172196 Pharmaceutical composition and method for treating hypogonadism |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110171200 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 07/14/2011 | US20110171186 Chondrocyte therapeutic delivery system |
| 07/14/2011 | CA2783468A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977386 Solid forms of selective androgen receptor modulators |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2526957C Long lasting insulin derivatives and methods thereof |
| 07/12/2011 | CA2480266C Use of an alpha2-adrenoreceptor antagonist for cns-related diseases |
| 07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/07/2011 | WO2011081937A1 Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
| 07/07/2011 | WO2011014707A3 Therapeutic agents for reducing parathyroid hormone levels |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166070 Method of preventing premature delivery |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165241 Bazedoxifene formulations with antioxidants |
| 07/07/2011 | US20110165139 Growth hormone secretion stimulator |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341066A1 Peptide having anti-diabetic activity and use thereof |
| 07/06/2011 | EP2341052A1 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2341044A1 Cycloalkylamine derivative |
| 07/06/2011 | EP2340017A2 Treatment of adrenal insufficiency |
| 07/06/2011 | EP1692101B1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP0998291B2 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/06/2011 | CN102115473A Bis-heterocyclic imidazolyl compounds |
| 07/06/2011 | CN102114226A Traditional Chinese medicine composition for treating precocious puberty and preparation and quality inspection method thereof |
| 07/06/2011 | CN102114206A Powder capable of restoring function of pancreatic islet and preparation method thereof |
| 07/06/2011 | CN102114185A Medicament for treating insulin resistance of type 2 diabetes |
| 07/06/2011 | CN102114133A Ointment with function of treating diabetes and preparation method thereof |
| 07/06/2011 | CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2400185C Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 06/30/2011 | WO2011079047A1 Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077046A1 Phenol derivatives and the pharmaceutical or cosmetic use thereof |